Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Arbutus Biopharma Corp | 157,600 | reported | 04 Aug 2025 | tx 1+157,600 |
| Omega Therapeutics, Inc. | 60,000 | reported | 09 Mar 2022 | tx 2+62,941 |
| ACTUATE THERAPEUTICS, INC. | 15,000 | reported | 21 May 2026 | tx 3+60,000 |
| ALIMERA SCIENCES INC | 2,252 | reported | 25 Feb 2023 | tx 1+2,252 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | ACTUATE THERAPEUTICS, INC. | 15,000 | 0.00 USD | deriv |
| 04 Aug 2025 | GRANT_AWARD | Arbutus Biopharma Corp | 157,600 | 0.00 USD | deriv |
| 22 May 2025 | GRANT_AWARD | ACTUATE THERAPEUTICS, INC. | 15,000 | 0.00 USD | deriv |
| 12 Aug 2024 | GRANT_AWARD | ACTUATE THERAPEUTICS, INC. | 30,000 | 0.00 USD | deriv |
| 25 Feb 2023 | GRANT_AWARD | ALIMERA SCIENCES INC | 2,252 | 0.00 USD | deriv |
| 09 Mar 2022 | GRANT_AWARD | Omega Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 03 Aug 2021 | PURCHASE | Omega Therapeutics, Inc. | 2,941 | 17.00 USD |